Frazier Life Sciences VIII L.P. 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-06 12:40 pm Purchase |
2024-03-04 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,862,478 7.800% |
21,052 (+0.24%) |
Filing |
| 2023-10-26 4:11 pm Purchase |
2023-10-24 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,841,426 9.400% |
96,108 (+1.10%) |
Filing |
| 2022-08-09 3:11 pm Purchase |
2022-08-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,745,318 14.600% |
263,411 (+3.11%) |
Filing |
| 2021-05-12 5:27 pm Sale |
2021-05-10 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,481,907 16.900% |
-2,084,883 (-19.73%) |
Filing |
| 2021-02-09 11:14 am Purchase |
2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 10,566,790 21.700% |
24,000 (+0.23%) |
Filing |
| 2020-10-06 2:42 pm Unchanged |
2020-10-06 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 10,542,790 24.100% |
0 (Unchanged) |
Filing |